Postoperative pain management: New, convenient analgesic therapies

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 4, 2007, Pages 391-399

  Power, Ian ^a   McCormack, Jon ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTACID AGENT; CARBAMAZEPINE; CORTICOSTEROID; EMLA; FENTANYL; GABAPENTIN; IBUPROFEN PLUS OXYCODONE; KETOROLAC; LIDOCAINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

APPLICATION SITE REACTION; APPLICATION SITE VESICLE; ARTHRITIS; ATAXIA; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DIABETIC NEUROPATHY; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; HALLUCINATION; HUMAN; HYPERALGESIA; IONTOPHORESIS; LEUKOPENIA; LIPID DIET; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROPATHIC PAIN; PANCREATITIS; PATIENT CONTROLLED ANALGESIA; PERIPHERAL EDEMA; PLASMA HALF LIFE; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRURITUS; PSYCHOSIS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SUSTAINED DRUG RELEASE; TOXIC HEPATITIS; TRANSDERMAL PATCH; TRIGEMINUS NEURALGIA; VOMITING; WEIGHT GAIN;

ACETAMINOPHEN; ANALGESICS; FENTANYL; HUMANS; OXYCODONE; PAIN, POSTOPERATIVE;

EID: 33947281153     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.4.391     Document Type: Review

References (64)

1. MCCLEANE GJM: Lamotrigine in the management of neuropathic pain: a review of the literature. Clin. J. Pain (2000) 16:321-326.
2. MAIZELS M, MCCARBERG B: Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am. Fam. Physician (2005) 71:483-490.
3. SINDRUP SH, JENSEN TS: Pharmacologic treatment of pain in polyneuropathy. Neurology (2000) 55:915-920.
4. WATSON CP, CHIPMAN M, REED K, EVANS RJ, BIRKETT N: Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain (1992) 48:29-36.
5. WATSON CP, VERNICH L, CHIPMAN M, REED K: Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology (1998) 51:1166-1171.
6. ATTAL N, CRUCCU G, HAANPAA M et al.: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. (2006) 13:1153-1169.
7. MELLICK LB. MELLICK GA: Successful treatment of reflex sympathetic dystrophy with gabapentin. Am. J. Emerg. Med. (1995) 13:96.
8. HWANG JH, YAKSH TL: Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg. Anesth. (1997) 22:249-256.
9. 1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. (2002) 303:1199-205.
10. CHENG JK, CHIOU LC: Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci. (2006) 100:471-486.
11. BONE M, CRITCHLEY P, BUGGY DJ: Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg. Anesth. Pain Med (2002) 27:481-486.
12. SERPELL MG: Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain (2002) 99:557-566.
13. DOGGRELL SA: Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opin. Pharmacother. (2005) 6:2535-2539.
14. MCLEAN MJ: Clinical pharmacokinetics of gabapentin. Neurology (1994) 44:S17-S22.
15. HEMPENSTALL K NJRARRA: Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med (2005) 2(7):e164.
16. FINNERUP NB, OTTO M, MCQUAY HJ, JENSEN TS, SINDRUP SH: Algorithm for neuropathic pain treatment: An evidence based proposal. Pain (2005) 118:289-305.
17. FIELD MJ, HOLLOMAN EF, MCCLEARY S, HUGHES J, SINGH L: Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J. Pharmacol. Exp. Ther. (1997) 282:1242-1246.
18. KAVOUSSI R: Pregabalin: from molecule to medicine. Eur. Neuropsychopharmacol. (2006) 16(Suppl. 2):S128-S133.
19. ROSENSTOCK J, TUCHMAN M, LAMOREAUX L, SHARMA U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain (2004) 110:628-638.
20. VAN SEVENTER R, FEISTER HA, YOUNG JP Jr, STOKER M, VERSAVEL M, RIGAUDY L: Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr. Med. Res. Opin. (2006) 22:375-384.
21. FREYNHAGEN R, BUSCHE P, KONRAD C, BALKENOHL M: [Effectiveness and time to onset of pregabalin in patients with neuropathic pain.]. Schmerz. (2006) 20(4):285-288, 290-292.
22. DWORKIN RH, CORBIN AE, YOUNG JP Jr et al: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2003) 60:1274-1283.
23. LESSER H, SHARMA U, LAMOREAUX L, POOLE RM: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology (2004) 63:2104-2110.
24. FAUGHT E: Pregabalin: the next new thing. Epilepsy Curr. (2005) 5:217-219.
25. HURLEY RWM, CHATTERJEA DBS, ROSE FENG MP, TAYLOR CPP, HAMMOND DLP: Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. [Miscellaneous Article]. Anesthesiology (2002) 97:1263-1273.
26. BARRY BW: Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J. Pharm. Sci. (2001) 14:101-114.
27. ASHBURN MA, STREISAND J, ZHANG J et al.: The iontophoresis of fentanyl citrate in humans. Anesthesiology (1995) 82:1146-1153.
28. IRSFELD S, KLEMENT W, LIPFERT P: Dermal anaesthesia: comparison of EMLA cream with iontophoretic local anaesthesia. Br. J. Anaesth. (1993) 71:375-378.
29. BERTOLUCCI LE: Introduction of antiinflammatory drugs by iontophoresis: Double-blind study. J. Orthop. Sports Phys. Ther. (1982) 4:103-108.
30. ASHBURN MA, STEPHEN RL, ACKERMAN E et al.: Iontophoretic delivery of morphine for postoperative analgesia. J. Pain Symptom Manage. (1992) 7:27-33.
31. SATHYAN G, JASKOWIAK J, EVASHENK M, GUPTA S: Characterisation of the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing, and comparison with iv fentanyl administration. Clin. Pharmacokinet. (2005) 44(Suppl. 1):7-15.
32. CHELLY JE, GRASS J, HOUSEMAN TW, MINKOWITZ H, PUE A: The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth. Analg. (2004) 98:427-433.
33. BROWN CR, MOODIE JE, BISLEY EJ: Safety and efficacy of Transfenta in the treatment of post-operative pain: a double-blind, single-center, placebo-controlled trial. 17th Annual Scientific Meeting of the American Pain Society. San Diego, CA, USA (5-8 November 1998) Abstr. 192.
34. VISCUSI ER, REYNOLDS L, TAIT S, MELSON T, IRANI H, ATKINSON LE: An iontophoretic fentanyl patient-controlled analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth. Analg. (2006) 102:188-194.
35. DAVIS MP, VARGA J, DICKERSON D, WALSH D, LEGRAND SB, LAGMAN R: Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support. Care Cancer (2003) 11:84-92.
36. LUGO RA, KERN SE: The pharmacokinetics of oxycodone. J. Pain. Palliat. Care Pharmacother. (2004) 18:17-30.
37. COLUZZI F, MATTIA C: Oxycodone. Pharmacological profile and clinical data in chronic pain management. Minerva Anestesiol. (2005) 71:451-460.
38. MURPHY EJ: Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth. Intensive Care (2005) 33:311-322.
39. DUBINSKY RM, KABBANI H, EL CHAMI Z, BOUTWELL C, ALI H: Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 63:959-965.
40. LEVY MH: Advancement of opioid analgesia with controlled-release oxycodone. Eur. J. Pain (2001) 5(Suppl. A):113-116.
41. MOORE A EJBJMH: Bandolier's Little Book of Pain, 1st edn. Oxford University Press, Oxford (2003).
42. KALSO E, POYHIA R, ONNELA P. LINKO K, TIGERSTEDT I, TAMMISTO T: Intravenous morphine and oxycodone for pain after abdominal surgery. Acta Anaesthesiol. Scand. (1991) 35:642-646.
43. CURTIS GB, JOHNSON GH, CLARK P et al.: Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur. J. Clin. Pharmacol. (1999) 55:425-429.
44. CALDWELL JR, HALE ME, BOYD RE et al.: Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J. Rheumatol. (1999) 26:862-869.
45. OLDFIELD V, PERRY CM: Oxycodone/Ibuprofen combination tablet: a review of its use in the management of acute pain. Drugs (2005) 65:2337-2354.
46. EDWARDS JE, MOORE RA, MCQUAY HJ: Single dose oxycodone and oxycodone plus paracetamol (acetominophen) for acute postoperative pain. Cochrane Database Syst. Rev. (2000) CD002763.
47. TIEN JH: Transdermal-controlled administration of oxycodone. J. Pharm. Sci. (1991) 80:741-743.
48. ANDERSON BJ, PONS G, AUTRET-LECA E, ALLEGART K, BOCCARD E: Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Pediatric Anesthesia (2005) 15:282-292.
49. GRAHAM GG, SCOTT KF: Mechanism of action of paracetamol. Am. J. Ther. (2005) 12:46-55.
50. PINI LA, SANDRINI M, VITALE G: The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur. J. Pharmacol. (1996) 308:31-40.
51. BJORKMAN R: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol. Scand. Suppl. (1995) 103:1-44.
52. BJORKMAN R, HALLMAN KM, HEDNER J, HEDNER T, HENNING M: Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain (1994) 57:259-264.
53. FLOUVAT B, LENEVEU A, FITOUSSI S, DELHOTAL-LANDES B, GENDRON A: Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int. J. Clin. Pharmacol. Ther. (2004) 42:50-57.
54. PEDUTO VA, BALLABIO M, STEFANINI S: Efficacy of propacetamol in the treatment of postoperative pain. Morphine-sparing effect in orthopedic surgery. Italian Collaborative Group on Propacetamol. Acta Anaesthesiol. Scand. (1998) 42:293-298.
55. BANNWARTH B, NETTER P, LAPICQUE F et al.: Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br. J. Clin. Pharmacol. (1992) 34:79-81.
56. KEHLET H, DAHL JB: The value of 'multimodal' or 'balanced analgesia' in postoperative pain treatment. Anesth. Analg. (1993) 77:1048-1056.
57. MIMOZ O, INCAGNOLI P, JOSSE C et al.: Analgesic efficacy and safety of nefopam versus propacetamol following hepatic resection. Anaesthesia (2001) 56:520-525.
58. VAN AKEN H, THYS L, VEEKMAN L, BUERKLE H: Assessing analgesia in single and repeated administrations of propacetamol for postoperative pain: comparison with morphine after dental surgery. Anesth. Analg. (2004) 98:159-165.
59. ZHOU TJ, TANG J, WHITE PF: Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement. Anesth. Analg. (2001) 92:1569-1575.
60. ROMSING J, MOINICHE S, DAHL JB: Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia. Br. J. Anaesth. (2002) 88:215-226.
61. SKJELBRED P, LOKKEN P: Paracetamol versus placebo: effects on post-operative course. Eur. J. Clin. Pharmacol. (1979) 15:27-33.
62. COBBY TF, CRIGHTON IM, KYRIAKIDES K, HOBBS GJ: Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br. J. Anaesth. (1999) 83:253-256.
63. HERNANDEZ-PALAZON J, TORTOSA JA, MARTINEZ-LAGE JF, PEREZ-FLORES D: Intravenous administration of propacetamol reduces morphine consumption after spinal fusion surgery. Anesthesia Analgesia (2001) 92:1473-1476.
64. KORPELA R, KORVENOJA P. MERETOJA OA: Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology (1999) 91:442-447.